US Regulation

关注

PreCheck Program Expands Manufacturing

由 AI 报道

The PreCheck program was launched to boost domestic pharmaceutical manufacturing in the US. It focuses on increasing production capacity and supply chain resilience. Regulatory developments also include blood-based tests for Alzheimer's detection.

本网站使用 Cookie

我们使用 Cookie 进行分析以改善我们的网站。 阅读我们的 隐私政策 以获取更多信息。
拒绝